BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15491751)

  • 1. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
    So J; Navari J; Wang FQ; Fishman DA
    Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
    So J; Wang FQ; Navari J; Schreher J; Fishman DA
    Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
    Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
    Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
    Wang FQ; Smicun Y; Calluzzo N; Fishman DA
    Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
    Fishman DA; Liu Y; Ellerbroek SM; Stack MS
    Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.
    Wang FQ; So J; Reierstad S; Fishman DA
    Int J Cancer; 2006 Feb; 118(4):879-88. PubMed ID: 16152587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
    Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
    Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
    Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
    Wang FQ; So J; Reierstad S; Fishman DA
    Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
    Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
    Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
    Wang FQ; Fisher J; Fishman DA
    Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Devine KM; Smicun Y; Hope JM; Fishman DA
    Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
    Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
    Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
    Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    RosanĂ² L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
    Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
    Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
    Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
    Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
    Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.